Designing Growth Strategies is in our DNA

U.S. Immunoglobulin Market Size, Share & Industry Analysis, By Product Type (Intravenous Immunoglobulin (IVIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Immune Thrombocytopenic Purpura, Multifocal Motor Neuropathy, and Others}, and Subcutaneous Immunoglobulin (SCIG) {Primary Immunodeficiency, Secondary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, and Others}), By Form (Liquid and Lyophilized), By End User (Hospitals, Clinics, and Homecare), and Country Forecast, 2026-2034

Last Updated :March 18, 2026 | Format:PDF | Report ID: 108226

 

Request a Free Sample Copy

man icon
Mail icon
Captcha refresh
Get 30-60 Hours of FREE Customization on this Report
Company Mapping:

Additional company profiling and benchmarking

Competitive Intelligence:

Advanced competitive landscape assessment

Segment Broadening:

Expanded segment-level coverage

Use-Case Analysis:

Tailored application and end-user evaluation

Extended Study Period:

Extended forecast and historical period

Geographic Granularity:

More detailed regional and country-level insights

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
  • 2021-2034
  • 2025
  • 2021-2024
  • 60